4th Quarter - Report — AMERICAN SOCIETY FOR MICROBIOLOGY for AMERICAN SOCIETY FOR MICROBIOLOGY (2023)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

AMERICAN SOCIETY FOR MICROBIOLOGY

Client

AMERICAN SOCIETY FOR MICROBIOLOGY

Income

—

Expenses

$50,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
4th Quarter - Report (this page)	Jan 19, 2024	$50,000	Replaced
4th Quarter - Amendment	Jan 19, 2024	$50,000	Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Science/Technology SCI

microbiome research and coordination, bioeconomy; implementation of the Chips and Science Act H.R. 4698, Health Animal Microbiome Study Act

Lobbyist	Covered position, as disclosed
AMALIA CORBY-EDWARDS New	—
NICHOLAS COX	—
MARY LEE WATTS	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP)

Bills named: H.R. 4698 (118th)

Agriculture AGR

Farm Bill reauthorization; study of animal microbiomes, H.R. 4698

Lobbyist	Covered position, as disclosed
AMALIA CORBY-EDWARDS	—
NICHOLAS COX New	—

Contacted: SENATE; Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 4698 (118th)

Medical/Disease Research/Clinical Labs MED

diagnostics regulation Saving Access to Laboratory Services Act, S. 1000, H.R. 1835

Lobbyist	Covered position, as disclosed
MARY LEE WATTS	—

Contacted: Office of Science & Technology Policy (OSTP); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH)

Bills named: H.R. 1835 (118th), S. 1000 (118th)

Health Issues HCR

Antimicrobial resistance; diagnostics development; advanced molecular detection; Pandemic and All-Hazards Preparedness Act reauthorization; S. 2333, H.R. 4420, H.R. 4421 PASTEUR Act S. 1355, H.R. 2940

Lobbyist	Covered position, as disclosed
NICHOLAS COX	—
MARY LEE WATTS	—

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); SENATE

Bills named: H.R. 2940 (118th), S. 1355 (118th), H.R. 4421 (118th), S. 2333 (118th), H.R. 4420 (118th)

Budget/Appropriations BUD

Fiscal year 2024 appropriations for NIH, CDC, NSF, DOE Office of Science, USDA research programs

Lobbyist	Covered position, as disclosed
NICHOLAS COX New	—
ALLEN SEGAL	—
MARY LEE WATTS	—

Contacted: SENATE; Centers For Disease Control & Prevention (CDC); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.